[1]丁鹏,吴开福,曲春城,等.脑血管淀粉样变性相关脑出血的手术疗效分析[J].中国临床神经外科杂志,2022,27(12):986-988.[doi:10.13798/j.issn.1009-153X.2022.12.009]
　DING Peng,WU Kai-fu,QU Chun-cheng,et al.Clinical efficacy of surgical treatment for cerebral amyloid angiopathy-associated intracerebral hemorrhage[J].,2022,27(12):986-988.[doi:10.13798/j.issn.1009-153X.2022.12.009]
点击复制

脑血管淀粉样变性相关脑出血的手术疗效分析()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
27
期数:
2022年12期
页码:
986-988
栏目:
论著
出版日期:
2022-12-31

文章信息/Info

Title:
Clinical efficacy of surgical treatment for cerebral amyloid angiopathy-associated intracerebral hemorrhage
文章编号:
1009-153X（2022）12-0986-03
作者:
丁鹏; 吴开福; 曲春城; 续继军
277599山东滕州，济宁医学院附属滕州市中心人民医院神经外科（丁鹏、吴开福、续继军）；250033济南，山东大学第二医院神经外科（曲春城）
Author(s):
DING Peng1;  WU Kai-fu1;  QU Chun-cheng2;  XU Ji-jun1
1. Department of Neurosurgery, Tengzhou Central People's Hospital Affiliated to Jining Medical University, Tengzhou 277599, China; 2. Department of Neurosurgery, The Second Hospital of Shandong University, Jinan 250033, China
关键词:
脑血管淀粉样变性相关脑出血; 手术; 疗效
Keywords:
Cerebral amyloid angiopathy-associated intracerebral hemorrhage;  Surgical treatment;  Clinical efficacy
分类号:
R743.34; R651.1+2
DOI:
10.13798/j.issn.1009-153X.2022.12.009
文献标志码:
A
摘要:
目的 探讨脑血管淀粉样变性相关脑出血（CAA-ICH）手术治疗的临床效果。方法 回顾性分析2014 年3月~2019年3月手术治疗的33例CAA-ICH的临床资料。结果 33例中，年龄<70岁15例（低龄组），年龄≥70岁18例（高龄组）。小骨窗手术5例，标准骨瓣开颅手术28例（骨瓣回置20例，去骨瓣减压8例）。术后24 h复查头部CT显示血肿清除率在60~95%，平均（80.5±4.2）％。低龄组血肿清除率[（81.6±4.3）%]与高龄组[（79.4±5.1）%]无统计学差异（P>0.05）。低龄组术后发生再出血发生率（6.67%）、肺部感染发生率（40.00%）、下肢静脉血栓发生率（13.33%）与高龄组（分别为11.11%、55.56%、33.33%）无统计学差异（P>0.05）。术后随访1年，按GOS评分：死亡5例，植物生存5例，重残9例，中残10例，恢复良好4例。低龄组预后良好率（60.00%；GOS评分4~5分）明显高于高龄组（27.78%；P<0.05）。结论 CAA-ICH术后并发症发生率高，总体预后不理想。相对年轻的CAA-ICH病人，显微手术是相对积极的治疗手段，可望获得较好的预后；但高龄CAA-ICH病人预后较差，全麻开颅手术应相对慎重。
Abstract:
Objective To investigate the clinical efficacy of surgery for patients with cerebral amyloid angiopathy-associated intracerebral hemorrhage (CAA-ICH). Methods The clinical data of 33 patients with CAA-ICH who underwent surgical treatment from March 2014 to March 2019 were analyzed retrospectively. Results Of 33 patients, 15 patients were younger than 70 years (younger group), and 18 patients were older than 70 years (older group). Five patients received small bone window craniotomy, and 28 standard craniotomy (bone flap replacement in 20 patients, and decompression in 8). Head CT 24 h after surgery showed that the hematoma clearance rate ranged from 60% to 95%, with an average of (80.5±4.2)%. There was no significant difference in the hematoma clearance rate between the younger group [(81.6±4.3)%]and the older group [(79.4±5.1)%; P>0.05]. There was no significant difference in the incidence of postoperative rebleeding (6.67%), pulmonary infection (40.00%), and lower limb venous thrombosis (13.33%) between the younger group and the older group (11.11%, 55.56%, 33.33%, respectively; P>0.05). The one-year follow-up showed a GOS score of 1 in 5 patients, a score of 2 in 5, a score of 3 in 9, a score of 4 in 10, and a score of 5 in 4. The good prognosis rate in the younger age group (60.00%; GOS score of 4~5) was significantly higher than that (27.78%) of the older group (P<0.05). Conclusions The complication rate of CAA-ICH is high, and the overall prognosis is poor. For younger CAA-ICH patients, microsurgery is a relatively progressive treatment and is expected to obtain a good prognosis. However, the prognosis of elderly CAA-ICH patients is poor, and craniotomy under general anesthesia should be relatively cautious.

参考文献/References:

[1]Charidimou A, Boulouis G, Gurol ME, et al. Emerging concepts in poradic cerebral amyloid angiopathy [J]. Brain, 2017, 140(7): 1829-1850.
[2]Pezzini A, Del Zotto E, Volonghi I, et al. Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage [J]. Curr Med Chem, 2009, 16: 2498-2513.
[3]Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges [J]. Lancet Neurol, 2010, 9(7): 689-701.
[4]Xu Qs, Fang MW, Feng YP. Recurrent cerebral amyloid angiopathy-related hemorrhage [J]. J Craniofac Surg, 2015, 26(2): e102-e104.
[5]Yamal JM, Hannay HJ, Gopinath S, et al. Glasgow outcome scale measures and impact on analysis and results of a randomized clinical trial of severe traumatic brain injury [J]. J Neurotrauma, 2019, 36(17): 2484-2492.
[6]Charidimou A, Frosch MP, Al-Shahi Salman R, et al. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0 [J]. Int J Stroke, 2019, 14(9): 956-971.
[7]Puy L, Cordonnier C. Sporadic cerebral amyloid angiopathy[J]. Geriatr Psychol Neuropsychiatr Vieil, 2019, 17(1): 73-82.
[8]Weber SA, Patel RK, Lutsep HL. Cerebral amyloid angiopathy: diagnosis and potential therapies [J]. Expert Rev Neurother, 2018, 18(6): 503-513.
[9]Mehndiratta P, Manjila S, Ostergard T, et al. Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management [J]. Neurosurg Focus, 2012, 32(4): E7.
[10]Charidimou A, Pantoni L, Love S. The concept of sporadic cerebral small vessel disease: a road map on key definitions and current concepts [J]. Int J Stroke, 2016, 11(1): 6-18.
[11]Arima H, Tzourio C, Anderson C, et al. Effects of perin-dopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial [J]. Stroke, 2010, 41: 394-396.
[12]Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment [J]. Expert Rev Neurother, 2019, 19(7): 679-694.
[13]Bardutzky J, Hieber M, Roelz R, et al. Cerebral amyloid angiopathy-related intracerebral hemorrhage: feasibility and safety of bedside catheter hematoma evacuation with urokinase [J]. Clin Neurol Neurosurg, 2020, 190: 105655.

相似文献/References:

[1]王振宇.脊髓髓内肿瘤诊断与治疗中若干问题的讨论[J].中国临床神经外科杂志,2015,(11):641.[doi:10.13798/j.issn.1009-153X.2015.11.001]
[2]黄　斌　李全才　张庭荣　郭运发　吴　昊　罗　坤.内镜 下与显微镜下经蝶手术治疗症状性Rathke囊肿的对比分析[J].中国临床神经外科杂志,2016,(05):264.[doi:10.13798/j.issn.1009-153X.2016.05.003]
　HUANG Bin,LI Quan-cai,ZHANG Ting-rong,et al.Surgery through transsphenoidal approach for symptomatic rathke cleft cysts: endoscopic surgery vs microsurgery[J].,2016,(12):264.[doi:10.13798/j.issn.1009-153X.2016.05.003]
[3]谢宝树　张　林　王　宇　贾　锋　殷玉华.复发性多发胶质母细胞瘤的预后分析[J].中国临床神经外科杂志,2016,(06):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
　XIE Bao-shu,ZHANG Lin,WANG Yu,et al.Analysis of prognoses in patients with recurrent multiple glioblastomas[J].,2016,(12):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
[4]陈正和　陈忠平.高级别胶质瘤的治疗现状及思考[J].中国临床神经外科杂志,2016,(06):350.[doi:10.13798/j.issn.1009-153X.2016.06.010]
[5]满明昊　李立宏　杨彦龙　李　敏　郭少春.颅脑损伤术后细胞免疫指标变化及脾多肽对其影响[J].中国临床神经外科杂志,2016,(06):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
　MAN Ming-hao,LI Li-hong,YANG Yan-yong,et al.Changes in peripheral cells immunity after operation and effect of spleen polypeptide on them in patients with traumatic brain injury[J].,2016,(12):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
[6]柯燕燕　周春霞　瞿建美　马丽萍.颞叶癫痫丙泊酚Wada试验中护理配合[J].中国临床神经外科杂志,2016,(06):380.[doi:10.13798/j.issn.1009-153X.2016.06.022]
[7]马　磊　张海红　郭　康　孙树凯　张　亮　贾　栋.神经导航辅助下手术治疗侧脑室脑膜瘤1例[J].中国临床神经外科杂志,2016,(04):255.[doi:10.13798/j.issn.1009-153X.2016.04.023]
[8]王亚平　贾晓雄　王　珺　王林林　谭溢涛　马德得　夏鹤春.神经内镜下与显微镜下经鼻蝶入路手术切除垂体腺瘤的疗效对比分析[J].中国临床神经外科杂志,2016,(03):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
　WANG Ya-ping,JIA Xiao-xiong,WANG-Jun,et al.Resection of pituitary adenomas by endoscopic and microscopic surgery via transnasal transsphenoidal approach: a comparative analysis[J].,2016,(12):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
[9]惠超杰　李文辉　曹立新　张广华.老年高血压小脑出血的小骨窗手术治疗[J].中国临床神经外科杂志,2016,(02):105.[doi:10.13798/j.issn.1009-153X.2016.02.016]
[10]赵建平　甘文芳　陈小奇　陈娇红　韩　琴　谢永香　张红波　孙彦辉.运动区脑肿瘤术后肢体功能障碍的康复护理[J].中国临床神经外科杂志,2016,(02):118.[doi:10.13798/j.issn.1009-153X.2016.02.023]

备注/Memo

备注/Memo:
（2022-04-30收稿，2022-11-09修回）
基金项目：山东省医药卫生科技发展计划项目（2017WS853）；济宁医学院教师科研扶持基金项目 （JYFC2018FKJ060）
通讯作者：续继军，E-mail：dingptz@163.com
更新日期/Last Update: 2022-01-31